Bioscience Health Innovations board member Justin Earl resigns; Daniel Schmidt appointed director

BioScience Health Innovations, Inc.

Justin Earl resigned from the board effective April 1, 2026, with no disagreement on company matters.
Daniel Schmidt appointed as director effective April 1, 2026, filling the vacancy.
Schmidt has served as the company's Chief Technology Officer since its inception.

item 5.02

BioScience Health Innovations, Inc. filing history →

Source: SEC EDGAR

accession 0001185185-26-001231

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.